These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 21745735

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma.
    Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Sasaki K, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N.
    Int J Oncol; 2011 Nov; 39(5):1099-107. PubMed ID: 21701775
    [Abstract] [Full Text] [Related]

  • 3. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
    Urol Oncol; 2012 Nov; 30(4):434-43. PubMed ID: 20843712
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.
    Uchida Y, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
    Urol Oncol; 2013 Jan; 31(1):115-23. PubMed ID: 21396852
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T, Seki N, Yoshino H, Itesako T, Hidaka H, Yamada Y, Tatarano S, Yonezawa T, Kinoshita T, Nakagawa M, Enokida H.
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [Abstract] [Full Text] [Related]

  • 7. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.
    Kinoshita T, Nohata N, Watanabe-Takano H, Yoshino H, Hidaka H, Fujimura L, Fuse M, Yamasaki T, Enokida H, Nakagawa M, Hanazawa T, Okamoto Y, Seki N.
    Int J Oncol; 2012 Jun; 40(6):1770-8. PubMed ID: 22378351
    [Abstract] [Full Text] [Related]

  • 8. Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.
    Yamasaki T, Yoshino H, Enokida H, Hidaka H, Chiyomaru T, Nohata N, Kinoshita T, Fuse M, Seki N, Nakagawa M.
    Int J Oncol; 2012 Jun; 40(6):1821-30. PubMed ID: 22378464
    [Abstract] [Full Text] [Related]

  • 9. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M, Matsubara H.
    Int J Cancer; 2010 Dec 15; 127(12):2804-14. PubMed ID: 21351259
    [Abstract] [Full Text] [Related]

  • 10. Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer.
    Chen WS, Leung CM, Pan HW, Hu LY, Li SC, Ho MR, Tsai KW.
    Oncol Rep; 2012 Sep 15; 28(3):1069-76. PubMed ID: 22766685
    [Abstract] [Full Text] [Related]

  • 11. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.
    Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N, Nakagawa M.
    Br J Cancer; 2011 Mar 01; 104(5):808-18. PubMed ID: 21304530
    [Abstract] [Full Text] [Related]

  • 12. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
    Chen Z, Tang ZY, He Y, Liu LF, Li DJ, Chen X.
    Oncol Res Treat; 2014 Mar 01; 37(11):658-64. PubMed ID: 25427583
    [Abstract] [Full Text] [Related]

  • 13. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.
    Zhai Q, Zhou L, Zhao C, Wan J, Yu Z, Guo X, Qin J, Chen J, Lu R.
    Biochem Biophys Res Commun; 2012 Mar 23; 419(4):621-6. PubMed ID: 22369946
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
    Zhang T, Liu M, Wang C, Lin C, Sun Y, Jin D.
    Anticancer Res; 2011 Nov 23; 31(11):3859-63. PubMed ID: 22110210
    [Abstract] [Full Text] [Related]

  • 15. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
    Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M.
    J Pathol; 2008 Dec 23; 216(4):418-27. PubMed ID: 18925646
    [Abstract] [Full Text] [Related]

  • 16. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.
    Isozaki Y, Hoshino I, Nohata N, Kinoshita T, Akutsu Y, Hanari N, Mori M, Yoneyama Y, Akanuma N, Takeshita N, Maruyama T, Seki N, Nishino N, Yoshida M, Matsubara H.
    Int J Oncol; 2012 Sep 23; 41(3):985-94. PubMed ID: 22752059
    [Abstract] [Full Text] [Related]

  • 17. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer.
    Yoshino H, Enokida H, Chiyomaru T, Tatarano S, Hidaka H, Yamasaki T, Gotannda T, Tachiwada T, Nohata N, Yamane T, Seki N, Nakagawa M.
    Biochem Biophys Res Commun; 2012 Jan 06; 417(1):588-93. PubMed ID: 22178073
    [Abstract] [Full Text] [Related]

  • 18. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
    Kinoshita T, Nohata N, Fuse M, Hanazawa T, Kikkawa N, Fujimura L, Watanabe-Takano H, Yamada Y, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N.
    Biochem Biophys Res Commun; 2012 Feb 10; 418(2):378-83. PubMed ID: 22266319
    [Abstract] [Full Text] [Related]

  • 19. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.
    Fuse M, Nohata N, Kojima S, Sakamoto S, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, Naya Y, Ichikawa T, Seki N.
    Int J Oncol; 2011 Apr 10; 38(4):1093-101. PubMed ID: 21258769
    [Abstract] [Full Text] [Related]

  • 20. miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.
    Qin Y, Dang X, Li W, Ma Q.
    Oncol Res; 2013 Apr 10; 21(6):353-63. PubMed ID: 25198665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.